Clinical Trials Directory

Trials / Completed

CompletedNCT05121415

Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy

Preventive and Personalized Medicine (2021-2023)

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Asfendiyarov Kazakh National Medical University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

To search for a genetic marker of hemorrhagic stroke complicating severe eclampsia, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with hemorrhagic stroke and normal control will be performed.

Detailed description

Detailed Description: Unrelated Korean subjects who have Spontaneous hemorrhagic stroke complicating severe eclampsia in pregnancy were recruited in the current study. Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with hemorrhagic stroke and normal control subjects free of hemorrhagic stroke

Conditions

Interventions

TypeNameDescription
GENETICSNP analysis of the DNASNP analysis of the DNA obtained from peripheral blood sample

Timeline

Start date
2021-10-23
Primary completion
2023-01-20
Completion
2023-01-20
First posted
2021-11-16
Last updated
2023-03-14

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05121415. Inclusion in this directory is not an endorsement.